In addition, we verified that CQ exhibits obvious protective effects against NLRP3-driven diseases in the model of LPS-induced peritonitis, DSS-induced colitis, and MSU-induced gouty inflammation, and provides new ideas as well as theoretical and practical basis for the prevention and treatment of NLRP3-driven diseases. Here, NLRP3 is linked to colitis.